Polianta Ltd’s DexCom DXCM Stock Holding History

Polianta Ltd’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-15,800	Closed	-$1.06M	–	76
2024 Q3	$1.06M	Buy	+15,800	New	+$1.3M	0.5%	63

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Polianta Ltd's DXCM Position: Q4 2024 in Review

Polianta Ltd sold out of DexCom (DXCM) in Q4 2024, closing a stake of 15,800 shares — an estimated $1.06M sold.

Polianta Ltd first reported a position in DXCM in Q3 2024 and held it in 1 quarter. The position peaked at $1.06M in Q3 2024. 950 funds tracked by Wall St. Rank hold DXCM as of Q4 2024.

Polianta Ltd reported no remaining DexCom position as of Q4 2024 after selling out during the quarter.
Polianta Ltd sold 15,800 DexCom shares in Q4 2024, an estimated $1.06M.
Polianta Ltd first reported a position in DexCom in Q3 2024 and held it in 1 quarter.
Polianta Ltd's DexCom position peaked at $1.06M in Q3 2024.
950 funds tracked by Wall St. Rank held DexCom as of Q4 2024.

Based on Polianta Ltd's 13F filing for Q4 2024, filed 16 Jan 2025.